Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) FCF Margin (2016 - 2025)

Rockwell Medical (RMTI) has disclosed FCF Margin for 16 consecutive years, with 9.64% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin fell 2407.0% year-over-year to 9.64%, compared with a TTM value of 3.88% through Sep 2025, down 655.0%, and an annual FY2024 reading of 3.14%, up 1474.0% over the prior year.
  • FCF Margin was 9.64% for Q3 2025 at Rockwell Medical, down from 10.45% in the prior quarter.
  • Across five years, FCF Margin topped out at 14.42% in Q3 2024 and bottomed at 81.0% in Q1 2021.
  • Average FCF Margin over 5 years is 19.75%, with a median of 11.11% recorded in 2024.
  • The sharpest move saw FCF Margin tumbled -3849bps in 2021, then surged 5758bps in 2022.
  • Year by year, FCF Margin stood at 59.61% in 2021, then skyrocketed by 97bps to 2.03% in 2022, then skyrocketed by 81bps to 0.39% in 2023, then soared by 590bps to 1.91% in 2024, then plummeted by -606bps to 9.64% in 2025.
  • Business Quant data shows FCF Margin for RMTI at 9.64% in Q3 2025, 10.45% in Q2 2025, and 18.77% in Q1 2025.